Avadel Pharmaceuticals (AVDL) Short Interest Ratio & Short Volume → Biden Nomination CANCELED? (From The Freeport Society) (Ad) Free AVDL Stock Alerts $15.49 -0.45 (-2.82%) (As of 05/17/2024 08:53 PM ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Avadel Pharmaceuticals Short Interest DataCurrent Short Volume4,800,000 sharesPrevious Short Volume10,610,000 sharesChange Vs. Previous Month-54.76%Dollar Volume Sold Short$87.17 millionShort Interest Ratio / Days to Cover3.8Last Record DateApril 30, 2024Outstanding Shares96,120,000 sharesPercentage of Shares Shorted4.99%Today's Trading Volume573,400 sharesAverage Trading Volume1,225,558 sharesToday's Volume Vs. Average47% Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatAVDL Short Interest Over TimeAVDL Days to Cover Over TimeAVDL Percentage of Float Shorted Over Time Ad Manward PressShocking: One AI startup's revenue could surge 4,735%Shocking: One AI Startup's Revenue Could Surge 4,735% While Nvidia gets all the attention, one small AI startup is quietly positioning itself to be the biggest winner.Click here to discover the AI chip company Avadel Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/20244,800,000 shares $87.17 million -54.8%N/A3.8 $18.16 4/15/202410,610,000 shares $0.00 +2.1%N/A8.7 $0.00 3/31/202410,390,000 shares $175.49 million -0.8%N/A8.4 $16.89 3/15/202410,470,000 shares $166.68 million -2.5%N/A8.2 $15.92 2/29/202410,740,000 shares $137.26 million +21.2%N/A8.5 $12.78 2/15/20248,860,000 shares $125.81 million +4.5%N/A9.2 $14.20Elon to Transform U.S. Economy? (Ad)A radical, potentially game-changing technology that threatens to destroy the trillion-dollar, “green energy” grift of the elites. And yet, while it threatens their wealth and power, it could be transformational for both the U.S. economy and your wealth.One company holds a near-total monopoly on it. 1/31/20248,480,000 shares $122.03 million +30.1%N/A9.2 $14.39 1/15/20246,520,000 shares $96.50 million +26.6%N/A7.7 $14.80 12/31/20235,150,000 shares $72.72 million +2.2%N/A6.8 $14.12 12/15/20235,040,000 shares $70.51 million +6.1%N/A7.5 $13.99 11/30/20234,750,000 shares $54.82 million -0.4%N/A7.6 $11.54 11/15/20234,770,000 shares $52.09 million +19.3%N/A8.3 $10.92 10/31/20234,000,000 shares $39.44 million +4.4%N/A6.9 $9.86 10/15/20233,830,000 shares $40.29 million +0.8%N/A6.8 $10.52 9/30/20233,800,000 shares $39.14 million +13.8%N/A6.6 $10.30 9/15/20233,340,000 shares $40.98 million +28.0%N/A5 $12.27 8/31/20232,610,000 shares $35.26 million -15.3%N/A3.5 $13.51 8/15/20233,080,000 shares $42.38 million -1.0%N/A3.9 $13.76 7/31/20233,110,000 shares $43.85 million -8.5%N/A3.7 $14.10 7/15/20233,400,000 shares $52.33 million -8.6%N/A3.4 $15.39 6/30/20233,720,000 shares $61.31 million -21.4%N/A3.8 $16.48 6/15/20234,730,000 shares $70.00 million +16.8%N/A4.6 $14.80 5/31/20234,050,000 shares $56.09 million +20.9%N/A4.4 $13.85 5/15/20233,350,000 shares $48.61 million -13.9%N/A3.7 $14.51 4/30/20233,890,000 shares $40.77 million +4.6%N/A4.5 $10.48 4/15/20233,720,000 shares $36.87 million +24.0%N/A5.8 $9.91 3/31/20233,000,000 shares $27.48 million -24.1%N/A4.9 $9.16 3/15/20233,950,000 shares $36.26 million -0.3%6.9%9 $9.18 2/28/20233,960,000 shares $39.40 million +0.3%7.3%7.9 $9.95 2/15/20233,950,000 shares $33.58 million +7.9%7.2%7.5 $8.50 1/31/20233,660,000 shares $27.54 million +9.6%6.5%6.1 $7.53 1/15/20233,340,000 shares $22.98 million -17.5%5.9%5.4 $6.88 12/30/20224,050,000 shares $29.00 million +3.3%7.1%6.8 $7.16 12/15/20223,920,000 shares $26.93 million +0.8%6.9%5.3 $6.87 11/30/20223,890,000 shares $35.67 million -2.5%6.9%5.7 $9.17 11/15/20223,990,000 shares $32.12 million -1.0%7.0%6.1 $8.05 10/31/20224,030,000 shares $26.56 million -1.2%7.3%7 $6.59 10/15/20224,080,000 shares $24.60 million +7.9%7.4%6.7 $6.03 9/30/20223,780,000 shares $18.94 million -4.6%6.9%5.3 $5.01 9/15/20223,960,000 shares $23.64 million +2.1%7.2%5.4 $5.97Elon to Transform U.S. Economy? (Ad)A radical, potentially game-changing technology that threatens to destroy the trillion-dollar, “green energy” grift of the elites. And yet, while it threatens their wealth and power, it could be transformational for both the U.S. economy and your wealth.One company holds a near-total monopoly on it. AVDL Short Interest - Frequently Asked Questions What is Avadel Pharmaceuticals' current short interest? Short interest is the volume of Avadel Pharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of April 30th, traders have sold 4,800,000 shares of AVDL short. Learn More on Avadel Pharmaceuticals' current short interest. What is a good short interest ratio for Avadel Pharmaceuticals? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. AVDL shares currently have a short interest ratio of 4.0. Learn More on Avadel Pharmaceuticals's short interest ratio. Which institutional investors are shorting Avadel Pharmaceuticals? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Avadel Pharmaceuticals: Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. Is Avadel Pharmaceuticals' short interest increasing or decreasing? Avadel Pharmaceuticals saw a decrease in short interest in April. As of April 30th, there was short interest totaling 4,800,000 shares, a decrease of 54.8% from the previous total of 10,610,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Avadel Pharmaceuticals' short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Avadel Pharmaceuticals: Day One Biopharmaceuticals, Inc. (18.47%), Dynavax Technologies Co. (14.99%), Pacira BioSciences, Inc. (7.73%), Morphic Holding, Inc. (12.82%), Akero Therapeutics, Inc. (12.44%), ANI Pharmaceuticals, Inc. (1.10%), Ligand Pharmaceuticals Incorporated (4.42%), Kiniksa Pharmaceuticals, Ltd. (5.51%), Arcus Biosciences, Inc. (16.36%), Gyre Therapeutics, Inc. (0.54%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short Avadel Pharmaceuticals stock? Short selling AVDL is an investing strategy that aims to generate trading profit from Avadel Pharmaceuticals as its price is falling. AVDL shares are trading down $0.45 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Avadel Pharmaceuticals? A short squeeze for Avadel Pharmaceuticals occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of AVDL, which in turn drives the price of the stock up even further. How often is Avadel Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including AVDL, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: DAWN Short Interest DVAX Short Interest PCRX Short Interest MORF Short Interest AKRO Short Interest ANIP Short Interest LGND Short Interest KNSA Short Interest RCUS Short Interest GYRE Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:AVDL) was last updated on 5/20/2024 by MarketBeat.com Staff From Our PartnersUrgent Nvidia WarningAltimetryThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaShocking: One AI startup's revenue could surge 4,735%Manward Press"The Biggest Drug Ever" Is ComingBehind the MarketsExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingElon’s New Device is About to Shock the WorldInvestorPlaceMost important medical advance in 100 yearsThe Oxford Club